Software Developer: Java/Calypso/AWS
RB (Reckitt Benckiser)1 day ago
Base Salary
$160k - $210k/yr
Responsibilities
- Develop Calypso custom extensions and integrations for the Post Trade & Custody stream.
- Design and build Java and Spring Boot microservices integrating with Calypso APIs, interfaces, and messaging channels.
- Build and maintain Kafka-based messaging and streaming pipelines for real-time data exchange.
- Architect and implement a scalable, resilient integration layer outside Calypso.
- Deploy, manage, and optimize integration services in AWS.
- Define integration contracts, data flows, and error-handling strategies with platform teams, architects, and business analysts.
- Participate in design reviews, code reviews, production troubleshooting, unit testing, integration testing, and UAT.
- Define Day-2 support processes and document technical designs, data flows, and integration patterns.
Requirements
- Strong hands-on experience building microservices with Java and Spring Boot.
- Demonstrated experience designing and implementing Kafka-based messaging and streaming solutions.
- Practical experience deploying and managing microservices in AWS, including services such as EC2, S3, or Lambda.
- Experience designing integration layers or middleware that interact with large enterprise platforms through APIs, messaging, or file-based interfaces.
- Prior Calypso experience, including its APIs, data model, or custom extensions, is preferred but not required.
- Experience in capital markets, treasury, or post-trade and custody systems is strongly preferred.
- Strong problem-solving, communication, and cross-functional collaboration skills.
- Must be eligible to obtain FOMC access.
Benefits
- Full-time, regular position; contractors and part-time engagements are not eligible.
- Position is located in New York.
- The role supports a mission-critical central banking and financial systems transformation program.
Tech Stack
Categories
About RB (Reckitt Benckiser)
Reckitt (formerly Reckitt Benckiser) is a global consumer-goods company that makes health, hygiene, and nutrition products sold through retailers, pharmacies, and e-commerce. Its portfolio includes brands such as Dettol/Lysol, Durex, Nurofen, Gaviscon, Mucinex, Enfamil, Finish, Vanish, and Harpic. Formed by the 1999 merger of Reckitt & Colman and Benckiser, the company is headquartered in Slough, UK, and is listed on the London Stock Exchange.